- Home
- PTGX vs DNUT Comparison
PTGX vs DNUT Comparison
Compare PTGX & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- DNUT
- Stock Information
- Founded
- PTGX 2006
- DNUT 1937
- Country
- PTGX United States
- DNUT United States
- Employees
- PTGX N/A
- DNUT N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- PTGX Health Care
- DNUT Consumer Staples
- Exchange
- PTGX Nasdaq
- DNUT Nasdaq
- Market Cap
- PTGX 2.8B
- DNUT 1.9B
- IPO Year
- PTGX 2016
- DNUT 2021
- Fundamental
- Price
- PTGX $47.91
- DNUT $11.35
- Analyst Decision
- PTGX Strong Buy
- DNUT Buy
- Analyst Count
- PTGX 7
- DNUT 9
- Target Price
- PTGX $52.83
- DNUT $15.56
- AVG Volume (30 Days)
- PTGX 450.1K
- DNUT 1.1M
- Earning Date
- PTGX 11-08-2024
- DNUT 11-07-2024
- Dividend Yield
- PTGX N/A
- DNUT 1.22%
- EPS Growth
- PTGX N/A
- DNUT N/A
- EPS
- PTGX 2.75
- DNUT N/A
- Revenue
- PTGX $319,120,000.00
- DNUT $1,739,779,000.00
- Revenue This Year
- PTGX $400.33
- DNUT $2.13
- Revenue Next Year
- PTGX N/A
- DNUT $7.84
- P/E Ratio
- PTGX $17.54
- DNUT N/A
- Revenue Growth
- PTGX 125.73
- DNUT 8.06
- 52 Week Low
- PTGX $13.76
- DNUT $9.18
- 52 Week High
- PTGX $48.89
- DNUT $17.84
- Technical
- Relative Strength Index (RSI)
- PTGX 60.40
- DNUT 56.23
- Support Level
- PTGX $45.33
- DNUT $11.46
- Resistance Level
- PTGX $48.89
- DNUT $11.82
- Average True Range (ATR)
- PTGX 1.28
- DNUT 0.29
- MACD
- PTGX 0.11
- DNUT 0.04
- Stochastic Oscillator
- PTGX 77.11
- DNUT 81.12
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.